7593VT HOLDINGS

3435SANKO TECHNO

5805SWCC

3965Capital Asset Planning

3387create restaurants holdings

2311EPCO

2702Mcdonald's Holdings(Japan)

7810Crossfor

3849NIPPON TECHNO LAB

6867LEADER ELECTRONICS

4012AXIS

9163Nareru Group

9028ZERO

3652Digital Media Professionals

7375REFINVERSE Group

3196HOTLAND HOLDINGS

3021Pacific Net

9531TOKYO GAS

3998SuRaLa Net

3113UNIVA Oak Holdings

8938GLOME Holdings

9904Verite

1904TAISEI ONCHO

8179Royal Holdings

8051YAMAZEN

6890Ferrotec

3968Segue Group

2492Infomart

3395Saint Marc Holdings

5253COVER

3753FLIGHT SOLUTIONS

7112CUBE

4284SOLXYZ

9740CENTRAL SECURITY PATROLS

6547GREENS

3277Sansei Landic

3457&Do Holdings

9857EIWA

3837Ad-Sol Nissin

7604UMENOHANA GROUP

3392DELICA FOODS HOLDINGS

9997BELLUNA

2404TETSUJIN Holdings

3173Cominix

6104SHIBAURA MACHINE

4381BPLATS

4326INTAGE HOLDINGS

4310Dream Incubator

3490Azplanning

6835Allied Telesis HD

4293SEPTENI HOLDINGS

7213LECIP HOLDINGS

7368HYOJITO

4572Carna Biosciences

8918LAND

2767TSUBURAYA FIELDS HOLDINGS

9960TOTECH

4674CRESCO

2173HAKUTEN

8737Akatsuki Corp

8920TOSHO

3097The Monogatari Corporation

5241Nihon OA Research

3950THE PACK

3030HUB

7699OMNI-PLUS SYSTEM

4760ALPHA

6840AKIBA Holdings

2449PRAP Japan

6837KYOSHA

4286CL Holdings

2488JTP

6073ASANTE

9622SPACE

3918PCI Solutions

2586FRUTA FRUTA

372ARENT

1430First-corporation

2384SBS Holdings

4563AnGes

6294OKADA AIYON

7640TOP CULTURE

6157NS TOOL

8119SANYEI CORPORATION

5011NICHIREKI GROUP

3916Digital Information Technologies

2999Home Position

6676BUFFALO

4891TMS

6912KIKUSUI HOLDINGS

9279GIFT HOLDINGS

6625JALCO Holdings

2154Open Up Group

2735WATTS

7637Hakudo

3401Teijin

6460SEGA SAMMY HOLDINGS

7771Nihon Seimitsu

3927Fuva Brain

7593VT HOLDINGS

3435SANKO TECHNO

5805SWCC

3965Capital Asset Planning

3387create restaurants holdings

2311EPCO

2702Mcdonald's Holdings(Japan)

7810Crossfor

3849NIPPON TECHNO LAB

6867LEADER ELECTRONICS

4012AXIS

9163Nareru Group

9028ZERO

3652Digital Media Professionals

7375REFINVERSE Group

3196HOTLAND HOLDINGS

3021Pacific Net

9531TOKYO GAS

3998SuRaLa Net

3113UNIVA Oak Holdings

8938GLOME Holdings

9904Verite

1904TAISEI ONCHO

8179Royal Holdings

8051YAMAZEN

6890Ferrotec

3968Segue Group

2492Infomart

3395Saint Marc Holdings

5253COVER

3753FLIGHT SOLUTIONS

7112CUBE

4284SOLXYZ

9740CENTRAL SECURITY PATROLS

6547GREENS

3277Sansei Landic

3457&Do Holdings

9857EIWA

3837Ad-Sol Nissin

7604UMENOHANA GROUP

3392DELICA FOODS HOLDINGS

9997BELLUNA

2404TETSUJIN Holdings

3173Cominix

6104SHIBAURA MACHINE

4381BPLATS

4326INTAGE HOLDINGS

4310Dream Incubator

3490Azplanning

6835Allied Telesis HD

4293SEPTENI HOLDINGS

7213LECIP HOLDINGS

7368HYOJITO

4572Carna Biosciences

8918LAND

2767TSUBURAYA FIELDS HOLDINGS

9960TOTECH

4674CRESCO

2173HAKUTEN

8737Akatsuki Corp

8920TOSHO

3097The Monogatari Corporation

5241Nihon OA Research

3950THE PACK

3030HUB

7699OMNI-PLUS SYSTEM

4760ALPHA

6840AKIBA Holdings

2449PRAP Japan

6837KYOSHA

4286CL Holdings

2488JTP

6073ASANTE

9622SPACE

3918PCI Solutions

2586FRUTA FRUTA

372ARENT

1430First-corporation

2384SBS Holdings

4563AnGes

6294OKADA AIYON

7640TOP CULTURE

6157NS TOOL

8119SANYEI CORPORATION

5011NICHIREKI GROUP

3916Digital Information Technologies

2999Home Position

6676BUFFALO

4891TMS

6912KIKUSUI HOLDINGS

9279GIFT HOLDINGS

6625JALCO Holdings

2154Open Up Group

2735WATTS

7637Hakudo

3401Teijin

6460SEGA SAMMY HOLDINGS

7771Nihon Seimitsu

3927Fuva Brain

What's New
New Analyst Reports
Information

What's New

  • 10/23/2026
  • NS TOOL(6157)
  • Analyst Report(Shared Research) : NS Tool announces price revisions
  • The Monogatari Corporation(3097)
  • Notice Regarding Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation and Partial Forfeiture of Allotment Rights
  • Open Up Group(2154)
  • Notice of Monthly Disclosure of Utilization Rates and Number of Domestic Engineers as of the end of September 2026
  • 10/22/2026
  • NS TOOL(6157)
  • Notice of Product Price Revision
  • 10/21/2026
  • INTAGE HOLDINGS(4326)
  • Notice of Disposal of Treasury Shares as Restricted Stock Compensation
  • Ferrotec(6890)
  • Analyst Report(Shared Research) : Ferrotec to acquire additional shares in equity-method affiliate, making it a specified subsidiary
  • WATTS(2735)
  • Financial Results for the Fiscal Year Ended August 31, 2026
  • YAMAZEN(8051)
  • Notice Concerning Revision of Consolidated Earnings Forecasts for the Second Quarter (Interim) and the Full Fiscal Year Ending March 2027
  • 10/20/2026
  • Carna Biosciences(4572)
  • Analyst Report(Shared Research) : Issuance of the fifth series of unsecured convertible bonds with share subscription rights through a third-party allotment under the bonds with share subscription rights issuance program agreement
  • 10/19/2026
  • Nareru Group(9163)
  • September 2026 KPI Announcement
  • YAMAZEN(8051)
  • Notice Regarding Status of Acquisition of Treasury Shares and its Completion
  • 10/16/2026
  • Royal Holdings(8179)
  • September Monthly Sales Report (Same-store sales)
  • WATTS(2735)
  • Notice Regarding Dividend of Surplus (Dividend Increase)
  • 10/15/2026
  • PRAP Japan(2449)
  • Consolidated Financial Results for the Fiscal Year Ended August 31, 2026 (Under Japanese GAAP)
  • Pacific Net(3021)
  • Consolidated Financial Results for the Three Months Ended August 31, 2026 (Under Japanese GAAP)
  • TMS(4891)
  • Notice of Completion of PMDA's 14-Day Review Period for the TMS-008 Phase IIa Clinical Trial
  • RENT(372A)
  • Consolidated Financial Results for the Three Months Ended August 31, 2026 (Under Japanese GAAP)
  • Nareru Group(9163)
  • Notice of Receipt of Dividend from a Consolidated Subsidiary
  • Notice Regarding the Transfer of Shares of ATJC Co., Ltd. (Change in Subsidiary)
  • First-corporation(1430)
  • [Summary]Financial Results for the first quarter of the fiscal year ending May 31,2027
  • 10/14/2026
  • create restaurants holdings(3387)
  • Notice of Sustainability Initiative to Upcycle Used Disposable Chopsticks into Furniture and Other Products
  • Notice of Transfer of Specified Subsidiary (Share Transfer)
  • Notice of Dividends from Surplus (Interim Dividend)
  • Notice of Extraordinary Income (Gain on Extinguishment of Tie-in Shares) from Absorption-type Merger of Consolidated Subsidiary
  • Financial Results of FY 2027 Q2(Supplementary Material)
  • Summary of Business Results for the Second Quarter Ending August 31, 2026 [IFRS] (Consolidated)
  • HUB(3030)
  • Non-consolidated Financial Results for the Six Months Ended August 31, 2026 (Under Japanese GAAP)
  • Digital Information Technologies(3916)
  • Notice Regarding Disposal of Treasury Shares as Restricted Stock for Directors
  • WATTS(2735)
  • Consolidated Financial Results for the Fiscal Year Ended August 31, 2026 (Under Japanese GAAP)
  • 10/13/2026
  • ALPHA(4760)
  • FY8/2026 Fact Sheet
  • Saint Marc Holdings(3395)
  • Monthly Sales Report September 2026
  • HOTLAND HOLDINGS(3196)
  • Monthly Sales Report (September)
  • TMS(4891)
  • Notice of Publication of a Research Paper on the Renoprotective Effects of an SMTP Compound in Acute Kidney Injury
  • 10/09/2026
  • Home Position(2999)
  • Non-consolidated Financial Results for the Fiscal Year Ended August 31, 2026 (Under Japanese GAAP)
  • ALPHA(4760)
  • Consolidated Financial Results for the Fiscal Year Ended August 31, 2026 (Under Japanese GAAP)
  • CENTRAL SECURITY PATROLS(9740)
  • Notice Regarding Change in Dividend Policy (Introduction of DOE as an Indicator and Progressive Dividends)
  • Notice Regarding Differences Between Consolidated Financial Results Forecasts and Actual Results for the Second Quarter (Interim Period) and Revision
  • The Monogatari Corporation(3097)
  • Notice Regarding Preliminary Monthly YoY Sales Results and Number of Restaurants for September 2026
  • CENTRAL SECURITY PATROLS(9740)
  • Consolidated Financial Results for the Six Months Ended August 31,2026(Under Japanese GAAP)
  • 10/08/2026
  • LAND(8918)
  • Consolidated Financial Results for the Six Months Ended August 31, 2026 (Under Japanese GAAP)
  • Azplanning(3490)
  • Consolidated Financial Results for the Six Months Ended August 31, 2026 (Under Japanese GAAP)
  • ASANTE(6073)
  • September Monthly Sales Report for FY Ending March 2027
  • HUB(3030)
  • September 2026 Monthly Report
  • WATTS(2735)
  • September 2026 Monthly YoY Sales Results and Number of Stores
  • LECIP HOLDINGS(7213)
  • Integrated Report 2026
  • 10/07/2026
  • Nareru Group(9163)
  • Notice Regarding Publication of an Analyst Report by FISCO Ltd.
  • 10/06/2026
  • Carna Biosciences(4572)
  • Analyst Report(Shared Research) : CTA signed with MD Anderson Cancer Center for investigator-initiated trial of monzosertib
  • Analyst Report(Shared Research) : Intention to Grant received in Europe for a patent covering CDC7 inhibitor monzosertib for the treatment of hematological malignancies
  • CRESCO(4674)
  • Notice Concerning Status of Own-Share Repurchase and Termination Thereof
  • Mcdonald's Holdings(Japan)(2702)
  • Monthly IR News
  • Verite(9904)
  • September 2026 Flash Report vs. LY
  • AnGes(4563)
  • Notice Regarding Grant Award to Support Development of a Subcutaneous Formulation of the Jointly Developed Tie2 Receptor Agonist (AV-001)
  • Teijin(3401)
  • Teijin Group Integrated Report 2026
  • 10/05/2026
  • The Monogatari Corporation(3097)
  • Notice Regarding Leakage of Personal Information Due to Unauthorized Access by a Third Party to the Member Management System of Our Official Yakiniku
  • CUBE(7112)
  • [FY12/26] Preliminary Monthly Sales Report of Directly Managed Stores for September 2026
  • GIFT HOLDINGS(9279)
  • September 2026 Monthly YoY Change in Sales and Number of Company-owned Stores
  • OKADA AIYON(6294)
  • Notice Concerning the Status of Share Repurchase
  • 10/02/2026
  • First-corporation(1430)
  • [ IR STREET REPORT ] : Profit Targets for Phase 1 of "First VISION 2031" Revised Upward. As Major General Contractors Become More Selective in Accepting Orders, the Company's Strengths as a Condominium Construction Specialist Stand Out Further Profit Growth in Sight!
  • 10/01/2026
  • SHIBAURA MACHINE(6104)
  • Notice Concerning Change in Major Shareholder
  • CRESCO(4674)
  • Notice Concerning Status of Own-Share Repurchase
  • BUFFALO(6676)
  • Notice Concerning Status of Purchase of Treasury Shares
  • Allied Telesis HD(6835)
  • Notice Regarding the Publication of an Analyst Report by Shared Research Inc.
  • INTAGE HOLDINGS(4326)
  • Notice Concerning Status of Purchase of Treasury Shares
  • YAMAZEN(8051)
  • Notice Regarding Status of Acquisition of Treasury Shares
  • UMENOHANA GROUP(7604)
  • [ IR STREET REPORT ] : Celebrating 50 years since its founding, UMENOHANA GROUP enters a new phase of growth. Aiming for a comeback driven by its dual pillars of restaurant dining and prepared food.
  • Teijin(3401)
  • (Disclosure Update) Notice on Completion of Business Integration Between Teijin Frontier Co., Ltd. and Asahi Kasei Advance Corporation
  • VT HOLDINGS(7593)
  • Storm Research Report (1Q 3/2027)
  • REFINVERSE Group(7375)
  • Analyst Report (TAKARADA GLOBAL ADVISORS) : Record Operating Profit Just a Passing Point. Both Segments Expanded Profits, with Further Upside Potential.
  • 09/30/2026
  • TMS(4891)
  • Notice of Submission of a Clinical Trial Plan Notification for a Phase IIa Clinical Trial of TMS-008 for Acute Kidney Injury
  • YAMAZEN(8051)
  • Notice Regarding the Resignation of Director
  • Notice Regarding Conclusion of Commitment Line Agreement
  • 09/29/2026
  • Carna Biosciences(4572)
  • Analyst Report(Shared Research) : Execution of agreement for the issuance of bonds with share subscription rights an issuance of 4th series unsecured convertible bonds with share subscription rights and new shares through third-party allotment
  • AnGes(4563)
  • Notice of Completion of Patient Enrollment in the Phase 2a Clinical Trial of Co-Developed Tie2 Receptor Agonist AV-001
  • SBS Holdings(2384)
  • Analyst Report(Shared Research) : SBS Holdings announces acquisition of shares in Mitsubishi Chemical Logistics Corporation
  • AnGes(4563)
  • Initiatives to Enhance Corporate Value through a Business Alliance with Growth Partners
  • 09/28/2026
  • SBS Holdings(2384)
  • Notice Concerning Business Acquisition by Subsidiary
  • Open Up Group(2154)
  • Notice of Reorganization of Management Structure
  • SBS Holdings(2384)
  • Notice Concerning Acquisition of Shares of Mitsubishi Chemical Logistics Corporation
  • Open Up Group(2154)
  • Amendment to the "Notice Concerning Changes in Representative Directors and Change of President"
  • &Do Holdings(3457)
  • Analyst Report(Shared Research) : Plan for compliance with requirements for continued listing (entry into improvement period)

    • New Analyst Reports

    10/22 NS TOOL CO.,LTD.(6157) Analyst Report(Shared Research) : NS Tool announces price revisions
    10/21 Ferrotec Corporation(6890) Analyst Report(Shared Research) : Ferrotec to acquire additional shares in equity-method affiliate, making it a specified subsidiary
    10/20 Carna Biosciences, Inc.(4572) Analyst Report(Shared Research) : Issuance of the fifth series of unsecured convertible bonds with share subscription rights through a third-party allotment under the bonds with share subscription rights issuance program agreement
    9/28 VT HOLDINGS CO.,LTD.(7593) Storm Research Report (1Q 3/2027)
    9/28 SBS Holdings,Inc.(2384) Analyst Report(Shared Research) : SBS Holdings announces acquisition of shares in Mitsubishi Chemical Logistics Corporation
    9/25 &Do Holdings Co.,Ltd.(3457) Analyst Report(Shared Research) : Plan for compliance with requirements for continued listing (entry into improvement period)
    9/25 Hakudo Co.,Ltd.(7637) Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q1 FY03/27 [Report Update]
    9/18 UMENOHANA GROUP CO.,LTD.(7604) [ IR STREET REPORT ] : Celebrating 50 years since its founding, UMENOHANA GROUP enters a new phase of growth. Aiming for a comeback driven by its dual pillars of restaurant dining and prepared food.
    9/18 TSUBURAYA FIELDS HOLDINGS INC.(2767) Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q1 FY03/27 [Report Update]
    9/17 Dream Incubator Inc.(4310) Analyst Report(Shared Research) : Capital and business alliance with Universal Materials Incubator to pursue GX and accelerate materials and chemicals business creation and industrial development
    9/15 First-corporation Inc.(1430) [ IR STREET REPORT ] : Profit Targets for Phase 1 of "First VISION 2031" Revised Upward. As Major General Contractors Become More Selective in Accepting Orders, the Company`s Strengths as a Condominium Construction Specialist Stand Out Further Profit Growth in Sight!
    9/15 Infomart Corporation(2492) Analyst Report(Shared Research) : Infomart makes K&C Factory a consolidated subsidiary
    9/14 REFINVERSE Group,Inc.(7375) Analyst Report (TAKARADA GLOBAL ADVISORS) : Record Operating Profit Just a Passing Point. Both Segments Expanded Profits, with Further Upside Potential.
    9/11 BUFFALO INC.(6676) Analyst Report(Shared Research) : Report update following earnings forecast revision

    Information

    Information

        9/1   What's new: GIFT HOLDINGS (9279)

        8/3   What's new: COVER (5253)

        8/3   What's new: NIPPON TECHNO LAB (3849)


    Newly Added Company

    Date：9/1
    GIFT HOLDINGS（9279：Prime）
    Date：8/3
    NIPPON TECHNO LAB（3849：AMBITIOUS）
    Date：8/3
    COVER（5253：Growth）

    Latest Video & Presentations

    Latest Video&Slides

    Company news
    provided by Timely Disclosure Network

    News Release

    Stock Code or Name:

    4565   Sosei Group Corporation

    10/22/2026 15:30 Nxera Pharma Submits Marketing Authorization Application for Vamorolone in South Korea for the Treatment of Duchenne Muscular Dystrophy
    10/20/2026 17:00 Introduction of the Executive Officer Performance Stock Option Plan and Issuance of Stock Acquisition Rights Under the Plan
    10/14/2026 16:00 Nxera Pharma Enters into Exclusive License, Supply and Commercialization Agreement with Synmosa for QUVIVIQ Across Eight Asia-Pacific Markets
    09/03/2026 15:30 Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress
    08/07/2026 15:30 Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
    08/07/2026 15:30 Consolidated Financial Results for the Six Months Ended June 30, 2026 (IFRS)
    06/30/2026 15:30 Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
    06/10/2026 15:30 OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical Companies and Cloud and AI Infrastructure Technology Providers
    05/19/2026 12:00 Notice of Partial Forfeiture (Decrease in the Number of Shares to be Issued, etc.) in Connection with the Issuance of New Shares Under the RSU Plan
    05/11/2026 15:30 Nxera Pharma Announces Progress of Out Licensing of GPCR-targeted Program and Participation in Series A Financing
    05/01/2026 15:30 Consolidated Financial Results for the Three Months Ended March 31, 2026 (IFRS)
    05/01/2026 15:30 Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
    04/20/2026 15:30 Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
    04/15/2026 16:30 Notice of Issuance of New Shares in Connection with J-ESOP and RSUs, and Determination of Payment Amount and Other Matters for Prior RSU Awards
    04/09/2026 08:30 Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
    03/25/2026 17:00 Notice Concerning New Management Structure
    03/05/2026 16:30 Nxera Pharma to Receive $3 Million Milestone Payment from Centessa Pharmaceuticals
    03/04/2026 15:30 Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
    02/26/2026 08:00 Notice of 2026 Annual General Meeting and Meeting Materials
    02/13/2026 19:00 Nxera Pharma Proposes Changes to its Board of Directors
    02/13/2026 15:30 Consolidated Financial Results for the FY2025 (IFRS)
    02/13/2026 15:30 Nxera Pharma to Record Extraordinary Loss on Impairment of Shares of Consolidated Subsidiary (Non-Consolidated)
    02/13/2026 15:30 Notice Concerning Reduction of Executive Compensation
    02/13/2026 15:30 Variance of Consolidated Results Between the Year Ended 31 December 2025 and the Previous Year
    02/13/2026 15:30 Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025
    02/12/2026 17:30 Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company
    02/12/2026 17:30 Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals
    01/19/2026 15:30 Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea
    01/13/2026 08:30 Nxera Pharma to Receive US$3.6 Million in Milestone Payment Pursuant to Research Collaboration with Centessa
    01/08/2026 16:30 Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
    12/22/2025 08:30 Nxera Announces Conclusion of Buyback for Existing Convertible Bonds
    12/19/2025 08:30 Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia
    12/11/2025 08:30 Nxera Announces Results of Buyback and Consent Solicitation for Existing Convertible Bonds
    12/08/2025 15:30 Notice Regarding Receipt of Dividends from Consolidated Subsidiary
    12/05/2025 08:30 Notice Regarding Change in Major Shareholder and Largest Shareholder
    11/26/2025 19:00 [Summary] Nxera Announces Buyback and Consent Solicitation for Existing Convertible Bonds
    11/19/2025 17:15 Nxera Introduces Employee Stock Ownership Plan (J-ESOP) for Employees Residing in Japan
    11/17/2025 15:30 Nxera Announces Focused Restructuring to Enhance Path to Profitability
    10/31/2025 15:30 Consolidated Financial Results for the Nine months Ended September 30, 2025 (IFRS)
    10/31/2025 15:30 Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2025
    Scroll Image
    スクロール画像